Olatz Arteaga Cabeza, PhD


Olatz Arteaga Cabeza is a biologist focused on the neuroprotective effects of antioxidants in hypoxic-ischemic encephalopathy. She graduated from the University of the Basque Country´s Biomedical Research PhD program in December 2015. Now, she is working on the evaluation of the effects of dendrimer-based n-acetyl-l-cysteine and erythropoietin therapy on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.

Jim Barkovich, MD

Professor Emeritus

Currently, I am still working with Dawn and Duan on brain injury in premies, working on the P01 (long term outcomes of neonatal encephalopathy), working (with Chris Walsh group) on better understanding of the biochemical pathway underpinnings of malformations of cortical development, and working with Kathy Millen (U of Washington) on the pathways underlying cerebellar developmental anomalies

Ariadna Borras Martinez, MD


"Dr. Ariadna Borras is a child neurologist by the University of Barcelona (Spain).  She is currently a visiting scholar in the Neuro Intensive Care Nursery at UCSF, focusing on clinical research. Her main research interest is the newborn neurology field, with special emphasis in acquired brain damage"

Alkisti Capper, PhD


Postdoctoral Scholar

Neonatal Hypoxic – Ischemic (HI) Encephalopathy is one of the most devastating conditions that can occur during the perinatal period, with therapeutic hypothermia (TH) being the only legitimate treatment option available to clinical practice. Still, the rate of death or disability after TH remains unacceptably high (60%).

Donna Ferriero, MD, MS


Donna Ferriero, MD MSc is the W. H. and Marie Wattis Distinguished Professor of Pediatrics and Chair of the Department of Pediatrics and Physician-in-Chief of the UCSF Benioff Children’s Hospital. She is also a Professor of Neurology and a member of the Biomedical Sciences Graduate Program. Dr. Ferriero is Director of the Neonatal Brain Disorder Laboratories and co-director of the Newborn Brain Research Institute at UCSF.  Her laboratory has been critical in defining the relationship of selectively vulnerable populations of neural cells during maturation-dependent injury.

Hannah Glass, MD, MAS

Professor Clinical Neurology

Dr. Hannah Glass is a neonatal neurologist and Director of Neonatal Critical Care Services at the UCSF Benioff Children's Hospital. She is also the program director of the Neonatal Neurology Fellowship Program. Dr. Glass has received funding from the NIH, March of Dimes, Cerebral Palsy Alliance, Patient Centered Outcomes Research Institute and the Pediatric Epilepsy Research Foundation to conduct clinical research that aims to improve developmental outcomes following newborn brain injury.

Fernando Gonzalez, MD

Prof of Clinical Pediatrics

My research is focused on determining how the full-term brain responds to acute injury during the neonatal period, and strategies to enhance neuroplasticity and long-term functional outcomes. My specific research goals are to: (1) clearly define the neuronal subpopulations that are vulnerable to ischemia and critical for neurodevelopment, (2) determine the mechanisms of injury and endogenous repair in the immature brain, and (3) define therapeutic strategies to enhance long-term function.

Xiangning Jiang, PhD

Associate Adjunct Professor

Hypoxic-ischemic encephalopathy remains a significant cause of death and disability in infants and children. Our research efforts are centered on understanding the molecular mechanisms of oxidative injury and the excitotoxic signaling mediated by the NMDA-type glutamate receptors in the developing brain. In particular, we investigate the role of postsynaptic density proteins, including the family of membrane-associated guanylate kinases (MAGUKs) and the Src family kinases, in regulating NMDA receptor function and related signaling networks in neonatal brain ischemia.

Xiao Liang, MS

Oakland Children's Hospital

I am intersted to understand the mechanisms of oxidative stress after stroke. I am using primary neuronal cultures to clarify the mechanisms underlying the modulation of Hypoxia Inducible Factors, such as Hif-1α, Hif-2α, and related signaling patheways in neonatal hypoxia-ischemia.

Ethan Lu, MD


I am an associate specialist of Neonatal Brain Disorder Laboratories. My research focuses on brain cholesterol synthesis and metabolism following neonatal brain hypoxia-ischemia. We use both in vivo mouse model (Vannucci procedure), and in vitro paradigm (oxygen-glucose deprivation in primary neurons) to study how hypoxia-ischemia regulates brain cholesterol homeostasis at early developmental stage; the unique pathway of cholesterol turnover in the brain; and the contribution of cholesterol dysfunction in brain structural and functional changes after neonatal hypoxia-ischemia.

Patrick McQuillen, MD

Professor in Residence

Shabnam Peyvandi, MD, MAS

Assoc Prof of Clin Pediatrics

Dr. Shabnam Peyvandi is a pediatric cardiologist that specializes in fetal diagnosis and management of congenital heart disease. Her main research interest is identifying fetal markers of neurodevelopmental outcomes in fetuses with critical CHD. She is an investigator in the clinical research program and collaborates with other members of the NBD center. Her current focus is utilizing maternal hyperoxia as a tool to understand fetal cerebral regulation and oxygenation in the setting of CHD as assessed by both fetal echocardiography and fetal brain MRI.